2.47 (-3.52%)

T-O: 2.57 (08:59:00)
Last updated: 17:00

Fundamental   5.0  
Technical   7.1  
Total Score   12.1  

 Chart Pattern+   Sector Trend+ 


iSaham Fundamental Trend

FCON: 0.64 | Sharpe Ratio: 0.29 | LTS: 7.09

Quarter Reports

Trailing Dividend

Financial Ratios

EPS 17.15 sen
Trailing PE (Sector Median: 18.2) 14.2
PEG -4.17
Altman Z 2.0
Beaver 0.048
Current Ratio 4.28
Debt-Equity (DE) Ratio 0.33
FCF Yield 1.0 %
Dividend Per Share (DPS) 8.5 sen
Revenue QoQ 7.76 %
Revenue YoY 3.26 %
Profit QoQ 18.76 %
Profit YoY -15.94 %
NTA QoQ 4.35 %
Profit Margin (Sector Median: 5.4) 7.94 %
ROE 7.02 %
ROIC 6.5 %
Dividend Yield (DY) 3.46 %

Fair Value

iSaham Fair Value: 1.47

Discounted Cash Flow (DCF)5.0% Growth 1.47
Discounted Cash Flow (DCF)4.8% Growth 0.975
Relative Valuation 3.17
Graham Formula 1.3
Graham Number 3.09
Net Tangible Asset (NTA) 2.4

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 48.36
Expected Revenue (M) 609.07
Expected Growth (%) 16.0



Market Cap: 340 M.

Number of Shares: 138 M.

Float: 32.39%.

Stock highly correlated with


AJIYA (95%)


REACH (95%)

Y.S.P Southeast Asia Holding Berhad, an investment holding company, is engaged in the manufacture, import, export, and trading of pharmaceutical products. It primarily offers pharmaceutical products, veterinary products, pharmaceutical fine chemicals, herbal products, over-the-counter products, and aquatic products. The company offers its products in various formats, such as gels, capsules, tablets, suppositories, creams, syrups, suspensions, and powder dosage forms. It has operations primarily in Malaysia, the Philippines, Myanmar, Singapore, Vietnam, Cambodia, and Indonesia. The company was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia. Y.S.P Southeast Asia Holding Berhad is a subsidiary of YSP SEA Investment Co., Ltd.

Sectors: Consumer Products, Healthcare, Pharmaceuticals

Code: 7178

Website: http://www.yspsah.com/

Related Links: Bursa | Annual Report | Announcement

Top Shareholdings

Updated on 29-Mar-2019

Shareholder Value (M)
YSP International Company Limited 129.34
Dato' Dr. Lee Fang Hsin 34.42
Skandinaviska Enskilda Banken AB 16.26
Employees Provident Fund Board 9.33
Tan Kong Han 8.25
Amal Pintas Sdn Bhd 5.88
PB Islamic Smallcap Fund 5.13
Lee Ling-Chin 4.55
Dr. Lee Fang Chuan @ Lee Fang Chen 4.5
Lee, Fang-Yu 3.58
Dr. Lee Fang-Jen 3.0
Datuk Dr. Anis Bin Ahmad 2.99
Yan Kai Yin 2.98
Wong Lok Jee @ Ong Lok Jee 2.96
Leong Foong Fin 2.93
Liao, Miao-Yi 2.79
Credit Suisse 2.72
Wong Ah Chiew 2.25
Tien Te Lee Biomedical Foundation 2.2
Lim Khuan Eng 2.17
Datuk Koay Soon Eng 2.14
Wong Ah Tim @ Ong Ah Tin 1.98
Wong Yee Hui 1.72
Tu Shu Yao 1.64
Lin, Chi-Jui 1.58
Kumpulan Wang Persaraan (Diperbadankan) 1.48
Chee Sai Mun 1.32
Lee, Ling-Fen 1.28